We are live on
!
Find out more
IMI
Intermolecular, Inc.
IMI
IMI
Delisted
IMI was delisted on the 19th of September, 2019.
25 hedge funds and large institutions have $17.9M invested in Intermolecular, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
2% less capital invested
Capital invested by funds: $18.3M → $17.9M (-$329K)
7% less funds holding
Funds holding: 27 → 25 (-2)
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$138K |
| 2 |
AL
Aspiriant LLC
Los Angeles,
California
|
+$70.2K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$57K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$12.7K |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.4K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$26.1K |
| 3 |
SIM
Spark Investment Management
New York
|
-$15.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.9K |
| 5 |
Goldman Sachs
New York
|
-$11K |
